Codoxo vs Machinify (2026)

AI Health Index verifiedOctober 15, 2026
Verdict

Health plan payment review is the shared market for Codoxo and Machinify, with different combinations of software and services. Codoxo combines fraud investigation, prepayment checks and clinical audit tools. Machinify spans coordination of benefits, liability recovery, audits, real time claim editing and pharmacy payment integrity. Codoxo's Fraud Scope gives investigators suspicious activity findings and supporting evidence. Clinical ClaimPilot organizes records, bills and potential adjustments so auditors can inspect source documents and approve or deny remaining charges before processing continues. Optional review and investigation services supplement the software. An unnamed health plan comparison reports substantial exposure detection, but lacks sample counts, dates and independent adjudication. It covers one product rather than the whole suite. Machinify offers Coordinate, Subrogate, Audit, Pay and Pharmacy through managed, hybrid or internal operating models. Pay edits and reprices claims before payment, while other modules address recovery and review. The company describes autonomous actions with expert oversight but does not specify which payment determinations require a person. Customer scale and aggregate recoveries come without false positive rates or appeal outcomes. The distinction is between Codoxo's documented investigator and auditor actions and Machinify's broader suite. Codoxo fits teams concentrating on investigation leads and evidence based clinical audit workflows. Machinify fits plans combining several payment integrity functions under a chosen service model.

The case for Codoxo
  • Investigators need evidence chains around suspicious provider activity.
  • Auditors need original records beside potential payment adjustments.
  • Clinical review must include approval of remaining charges before processing.
  • Fraud detection and optional investigation services are central.
The case for Machinify
  • Coordination of benefits and liability recovery are both in scope.
  • The plan needs prepayment editing and repricing.
  • Pharmacy payment integrity needs a dedicated module.
  • The plan wants managed, hybrid or internal operations across modules.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Codoxo and Machinify are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Codoxo Machinify
Primary category RCM & Prior Auth AI RCM & Prior Auth AI
Founded 2017 2016
Headquarters Duluth, Georgia, United States Palo Alto, California
Website codoxo.com machinify.com
Attribute Matrix

Side by Side

Select any grade to read the note behind it.

Axis
C
Codoxo
M
Machinify
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each vendor in one paragraph

Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.

Codoxo

Codoxo helps health plans, pharmacy benefit managers and government agencies find payment errors, investigate fraud and review complex claims. Its Unified Cost Containment Platform combines a proprietary Forensic AI engine with generative AI applications for payer operations. The company was founded in 2017 and is based in Duluth, Georgia.

Source: AI Health Index, October 2026

Machinify

Machinify sells payment integrity software and services to health plans, and it exists as the result of several companies being combined under one private equity owner. Anyone searching for the constituent brands is looking at businesses that now sit inside this one.

Source: AI Health Index, October 2026

FAQ

Questions buyers ask

How are Codoxo and Machinify priced and sold?

For Codoxo, the total cost remains dependent on the selected software and contracted service scope.

Five modular products (Coordinate, Subrogate, Audit, Pay, Pharmacy) are sold to health plans, and each can be launched fully managed by Machinify's team, in a hybrid model, or insourced with the plan's own analysts and reviewers, which is the main driver of what a plan is buying. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.

Which settings and specialties do Codoxo and Machinify cover?

In Codoxo's case, the national health plan case establishes actual payer use of Fraud Scope, while other product pages broaden the intended scope. Other claim types and lines of business have no comparable results.

For Machinify, coverage is specialty agnostic because claims arrive from everywhere. United States only, which is inherent since payment integrity is a function of a specific reimbursement system. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.

What evidence is published for Codoxo and Machinify?

With Codoxo, the customer is unnamed, and the account lacks a calendar period, sample counts and independent adjudication.

In Machinify's case, the products page points to a KLAS First Look report (October 2025) on customer ratings, which measures customer experience rather than the accuracy of findings. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.

How much do Codoxo and Machinify leave to the clinician?

For Codoxo, the promise to avoid denials, appeals and resubmissions entirely describes a workflow outcome without establishing a measured guarantee for individual claims. Across the wider product suite, nothing sets confidence thresholds, mandatory escalation conditions or recovery procedures for mistaken recommendations.

With Machinify, the home page describes task specific agents that execute work independently; the products page says the company combines autonomous actions with human expert oversight, that its systems do not just detect problems but fix them, and that Pay edits and reprices claims in real time before payment. A plan can run each product fully managed by Machinify's experts, or pair it with its own analysts and reviewers. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified October 15, 2026. No vendor pays for placement.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.

Disclosure

Codoxo is based in Duluth, Georgia. Palo Alto based Machinify combines businesses under New Mountain Capital, including Rawlings and Apixio's payment integrity business; Apixio's Connected Care business went separately to Datavant. Neither publishes a current rate card or complete fee basis.